The University of Texas at San Antonio (UTSA) and GenCure are working together on the development of cellular therapy products and services under a new master services agreement. GenCure will provide UTSA with research starting materials, and UTSA will offer testing services for materials produced by GenCure. The collaboration aims to boost the clinical application of stem cell therapeutics.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
